Found: 13
Select item for more details and to access through your institution.
Correction to: HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction induced injury.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury.
- Published in:
- Skeletal Muscle, 2018, v. 8, n. 1, p. N.PAG, doi. 10.1186/s13395-018-0179-5
- By:
- Publication type:
- Article
Satellite cell therapy - from mice to men.
- Published in:
- Skeletal Muscle, 2013, v. 3, n. 1, p. 1, doi. 10.1186/2044-5040-3-2
- By:
- Publication type:
- Article
Genetic Ablation of CD38 Protects against Western Diet-Induced Exercise Intolerance and Metabolic Inflexibility.
- Published in:
- PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0134927
- By:
- Publication type:
- Article
Human and Mouse Skeletal Muscle Stem Cells: Convergent and Divergent Mechanisms of Myogenesis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0090398
- By:
- Publication type:
- Article
Ligand activation of peroxisome proliferator-activated receptor-{beta}/{delta} (PPAR{beta}/{delta}) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms.
- Published in:
- Carcinogenesis, 2008, v. 29, n. 1, p. 169, doi. 10.1093/carcin/bgm209
- By:
- Publication type:
- Article
Peroxisome proliferator-activated receptor- /{delta} (PPAR /{delta}) ligands do not potentiate growth of human cancer cell lines.
- Published in:
- Carcinogenesis, 2007, v. 28, n. 12, p. 2641, doi. 10.1093/carcin/bgm183
- By:
- Publication type:
- Article
Semi‐Mechanistic PK/PD Modeling and Simulation of Irreversible BTK Inhibition to Support Dose Selection of Tirabrutinib in Subjects with RA.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 416, doi. 10.1002/cpt.2439
- By:
- Publication type:
- Article
Expression profiling of Peroxisome proliferator-activated receptor-delta (PPAR-delta) in mouse tissues using tissue microarray.
- Published in:
- Histochemistry & Cell Biology, 2007, v. 127, n. 5, p. 485, doi. 10.1007/s00418-007-0279-5
- By:
- Publication type:
- Article
Effect of Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 9, p. 1017, doi. 10.1002/jcph.2260
- By:
- Publication type:
- Article
Pharmacokinetics, pharmacodynamics, safety and tolerability of cilofexor, a novel nonsteroidal Farnesoid X receptor agonist, in healthy volunteers.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 3, p. 536, doi. 10.1111/cts.13469
- By:
- Publication type:
- Article
Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 616, p. 1, doi. 10.1126/scitranslmed.abe8939
- By:
- Publication type:
- Article
Lack of evidence for GDF11 as a rejuvenator of aged skeletal muscle satellite cells.
- Published in:
- Aging Cell, 2016, v. 15, n. 3, p. 582, doi. 10.1111/acel.12475
- By:
- Publication type:
- Article